Oral Bedtime Melatonin in Critically Ill Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT06156059
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT06156059
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06156059. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (anticipated); primary completion 2026-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Bedtime Melatonin in Critically Ill Patients
- Acronym
- Mel-ICU
- Condition
- Septic Shock
- Condition
- Stroke Hemorrhagic
- Condition
- Strokes Thrombotic
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Oral Bedtime Melatonin
- Intervention (Drug)
- Placebo suspension or capsule
- Lead sponsor
- Hospital San Carlos, Madrid
- Collaborator
- Universidad Complutense de Madrid
Record details
- Record id
cardio:ct-nct06156059- Content hash
28a8ade96e13a4a495e45c425779e4b46977a3c4e2953f6aa374511badb982f7